<DOC>
	<DOCNO>NCT01493934</DOCNO>
	<brief_summary>Insulin resistance , characterise depressed cellular sensitivity insulin insulin-sensitive organ , central feature metabolic syndrome . In people diabetes mellitus , presence metabolic syndrome lead increase mortality , whatever cause , , majority , cardiovascular disease . In patient type 2 diabetes mellitus , presence metabolic syndrome lead increase major adverse cardiovascular event . The prevalence metabolic syndrome lead grow near future , increase diabetes mellitus obesity prevalence . Actually , simple tool measure insulin resistance . The gold standard technique remain hyperinsulinemic euglycemic clamp . However , complexity length technique render unsuitable routine clinical use . Many method index propose assess insulin resistance human , none show enough relevance use clinical use . Within investigator U877 INSERM team , investigator previously perform vivo biodistribution study 6-DIG ( 6-deoxy-6-iodo-D-glucose ) , new tracer glucose transport , radiolabelled with123 iodine , without insulin , one hand genetically diabetic mouse ( db/db ) , consequently severe insulin resistance hand rat acquire insulin resistance `` fructose diet '' . The investigator demonstrate 6-DIG able identify vivo slight glucose transport variation insulin sensible organ . Then , investigator develop fast simple image protocol small animal gamma camera , allow obtain insulin resistance index organ , directly transferable human . The investigator project transfer human measurement technique , perfectly validate animal . The main goal monocentric phase I-II study evaluate tolerance insulin resistance measurement technique 6DIG scintigraphy , healthy volunteer diabetic patient . The investigator plan enrol 6 healthy volunteer 6 type 2 diabetic patient . The investigator secondary goal evaluate feasibility reproducibility measurement technique , follow pharmacokinetic ass efficacy 6-DIG measure insulin resistance .</brief_summary>
	<brief_title>Development Fast Measurement Technique Insulin Resistance Human</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Healthy volunteer Aged 35 et 60 year old Body mass index 20 25 Waist measurement &lt; 94 cm men &lt; 80 cm woman Normal basal glycemia , 3,8 5,8 mmol/l Normal basal insulinemia , 3 13 Î¼UI/ml HbA1c &lt; 6 % Total cholesterol &lt; 2 g/l LDL cholesterol &lt; 1,6 g/l HDL cholesterol 0,4 g/l men 0,5 g/l woman Triglyceride level &lt; 1,5 g/l For woman menopausal since last one year surgically sterilise : Ongoing contraception , physical hormonal , except local method ( spermicidal , diaphragm , condom , cape ) Type 2 diabetic patient Aged 35 et 60 year old Stable type 2 diabetes mellitus : ketoacidosis sign last month HbA1c 6 8 % 3 month study inclusion Monotherapy metformin diet For woman menopausal since last one year surgically sterilise : Ongoing contraception , physical hormonal , except local method ( spermicidal , diaphragm , condom , cape ) Diabetes mellitus previously know Other ongoing progressive illness Psychiatric illness , need chronic treatment Previous history myocardial infarction , coronary artery disease , cardiac rhythm trouble , stroke , epilepsy , cranial trauma , pituitary surgery , disease likely reduce ability absorption , diffusion excretion radiotracer . Severe hypertension define par SAP &gt; 180 mmHg and/or DAP &gt; 110 mmHg Allergy one component product use study Nuclear medicine examination 30 day prior study inclusion Treatment likely interfere glucose metabolism Alcohol drug intoxication Vegetarian restrictive lowcalory diet , Pregnant , parturient breastfeed woman , Inappropriate way life Type 2 diabetic patient . Previous history myocardial infarction Severe hypertension define par SAP &gt; 180 mmHg and/or DAP &gt; 110 mmHg Previous history coronary artery disease , cardiac rhythm trouble , stroke , epilepsy , cranial trauma , pituitary surgery , disease likely reduce ability absorption , diffusion excretion radiotracer . Psychiatric illness , need chronic treatment Ongoing insulin treatment Ongoing treatment metformin , likely interfere glucose metabolism Previous history disease likely reduce ability absorption , diffusion excretion radiotracer Allergy one component product use study Nuclear medicine examination 30 day prior study inclusion Alcohol drug intoxication Vegetarian restrictive lowcalory diet , Pregnant , parturient breastfeed woman , Inappropriate way life</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>metabolic syndrome</keyword>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>Scintigraphy</keyword>
</DOC>